Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

XAIR
Beyond Air, Inc. Common Stock
stock NASDAQ

At Close
Oct 20, 2025 3:59:30 PM EDT
2.46USD+4.681%(+0.11)121,117
2.44Bid   2.46Ask   0.02Spread
Pre-market
Oct 20, 2025 9:02:30 AM EDT
2.38USD+1.277%(+0.03)685
After-hours
Oct 20, 2025 4:42:30 PM EDT
2.54USD+3.252%(+0.08)8,921
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 27, 2022
08:00AM EST  Beyond Air Schedules Third Fiscal Quarter 2022   GlobeNewswire Inc
Jan 24, 2022
04:49PM EST  Beyond Air Inc Files For Mixed Shelf Offering Of Up To $200M   Benzinga
Dec 9, 2021
09:55PM EST  Mid-Afternoon Market Update: Nasdaq Falls Over 1%; Reata Pharmaceuticals Shares Plummet   Benzinga
09:54PM EST  Mid-Day Market Update: Crude Oil Down 1%; Inspira Technologies Shares Spike Higher   Benzinga
09:47PM EST  Beyond Air Says Base On FDA Communications, Co. No Longer Believes US Commercial Launch Of LungFit PH Will Take Place Prior To Dec. 31   Benzinga
08:30AM EST  Beyond Air Provides Regulatory Update for   GlobeNewswire Inc
Dec 1, 2021
08:00AM EST  Dr. Colin brings four decades of clinical experience in pediatric pulmonology to Beyond Air, with research spanning respiratory physiology, Cystic Fibrosis, and lung infections culminating in over 120 peer-reviewed publications and 250 global lectures   GlobeNewswire Inc
Nov 18, 2021
04:05PM EST  Beyond Air Announces $30 Million of Committed Capital   GlobeNewswire Inc
Nov 12, 2021
09:17AM EST  Truist Securities Maintains Buy on Beyond Air, Raises Price Target to $16   Benzinga
Nov 11, 2021
04:22PM EST  Beyond Air Q2 EPS $(0.36) Misses $(0.28) Estimate   Benzinga
04:05PM EST  U.S. FDA actively reviewing premarket approval (PMA) submission for LungFit PH to treat persistent pulmonary hypertension of the newborn (PPHN); Remain on track for commercial launch in the fourth quarter of calendar year 2021   GlobeNewswire Inc
03:55AM EST  Earnings Scheduled For November 11, 2021   Benzinga
Nov 10, 2021
11:01AM EST  Earnings Preview For Beyond Air   Benzinga
Nov 4, 2021
07:30AM EDT  $23.9 million committed in concurrent equity private placement to form Beyond Cancer that will leverage Beyond Airs nitric oxide (NO) expertise and take over development of current solid tumor pipeline   GlobeNewswire Inc
Nov 2, 2021
08:00AM EDT  Beyond Air to Participate in the Piper Sandler 33rd   GlobeNewswire Inc
Oct 25, 2021
08:00AM EDT  Beyond Air Schedules Second Fiscal Quarter 2022   GlobeNewswire Inc
Oct 20, 2021
08:11AM EDT  UPDATE: Beyond Air Says 'At the time of data cutoff, 8 subjects were successfully titrated up to 250 ppm NO with none having titrated down while in the study'   Benzinga
08:11AM EDT  UPDATE: Beyond Air Reports 'Interim results show that 250 parts per million (ppm) nitric oxide (NO) was well-tolerated with no study discontinuations or treatment-related serious adverse events observed'   Benzinga
08:10AM EDT  Beyond Air Reports Interim Results From LungFit GO Pilot Study Using High Concentration Inhaled Nitric Oxide Self-Administered At-Home For Nontuberculous Mycobaterial Lung Disease   Benzinga
08:00AM EDT  Interim results show that 250 parts per million (ppm) nitric oxide (NO) was well-tolerated with no study discontinuations or treatment-related serious adverse events observed   GlobeNewswire Inc
Sep 21, 2021
04:31PM EDT  Beyond Air Reports FDA Inspection Of Co. Facilities For LungFit Ongoing; Co. Says US Commercial Launch Remains On Track For Q4   Benzinga
04:30PM EDT  FDA inspection of facilities is ongoing; US commercial launch remains on track for 4Q CY2021, pending FDA approval   GlobeNewswire Inc
Sep 14, 2021
07:30AM EDT  Beyond Air to Present at the Oppenheimer Fall   GlobeNewswire Inc
Aug 21, 2021
06:54AM EDT  Beyond Air, Inc. (XAIR) announced that it has appointed Douglas Larson as Chief Financial Officer, succeeding Douglas Beck effective September 1, 2021.   RTTNews
Aug 20, 2021
04:16PM EDT  Beyond Air Names Douglas Larson As CFO   Benzinga
04:15PM EDT  Beyond Air Announces CFO Transition   GlobeNewswire Inc
Aug 10, 2021
04:46PM EDT  Beyond Air: Q1 Earnings Insights   Benzinga
04:46PM EDT  Beyond Air Q1 EPS $(0.31) Misses $(0.21) Estimate   Benzinga
04:05AM EDT  Earnings Scheduled For August 10, 2021   Benzinga
Jul 20, 2021
07:30AM EDT  Beyond Air Schedules First Fiscal Quarter 2022   GlobeNewswire Inc
Jul 13, 2021
11:07AM EDT  Beyond Air: Return On Capital Employed Insights   Benzinga
Jul 8, 2021
04:15PM EDT  Beyond Air Announces Participation at Upcoming   GlobeNewswire Inc
Jun 30, 2021
10:52AM EDT  Beyond Air Insights: Return On Capital Employed   Benzinga
Jun 23, 2021
04:44AM EDT  44 Biggest Movers From Yesterday   Benzinga
Jun 22, 2021
12:11PM EDT  Shares of Beyond Air, Inc. (XAIR) are gaining over 13% on Tuesday morning despite no stock-related news to drive the shares.   RTTNews
08:46AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Jun. 22, 2021: SPLK, TRCH, ALF, KCAC, XAIR   Benzinga
Jun 10, 2021
04:12PM EDT  Beyond Air Reports FY21 EPS $(1.27) Up From $(1.78) YoY, Sales $873K Down from $1.39M YoY   Benzinga
04:05PM EDT  Submitted first premarket approval (PMA) application in the Companys history to FDA for LungFit PH to treat persistent pulmonary hypertension of the newborn (PPHN); Company preparing for commercial launch in the fourth quarter of calendar year 2021   GlobeNewswire Inc
04:04AM EDT  Earnings Scheduled For June 10, 2021   Benzinga
Jun 9, 2021
10:28AM EDT  Preview: Beyond Air's Earnings   Benzinga
May 26, 2021
09:07AM EDT  Beyond Air Acquires Full Global Rights To LungFit PH After   RTTNews
07:38AM EDT  Beyond Air Reaches Settlement Agreement With Circassia For LungFit PH; Co. To Pay Circassia The $10.5M Received In 2019 Over A Two-Yer Period   Benzinga
07:37AM EDT  Beyond Air Reaches Settlement Agreement With Circassia For LungFit PH   RTTNews
07:30AM EDT  Beyond Air Reaches Settlement Agreement with Circassia   GlobeNewswire Inc
May 25, 2021
07:30AM EDT  Beyond Air Schedules Fiscal Year 2021 Financial   GlobeNewswire Inc
May 20, 2021
08:00AM EDT  Beyond Air Strengthens Commercial Leadership Team with   GlobeNewswire Inc
May 13, 2021
08:03AM EDT  Beyond Air Highlights Presentation Of Data In Hospitalized Patients With Viral Lung Infections From LungFit PRO Programs At ATS 2021   Benzinga
08:00AM EDT  Interim analysis from the ongoing, open-label, randomized acute viral pneumonia (including COVID-19) pilot study shows 150 ppm nitric oxide (NO)administered with LungFit PRO is well-tolerated with no treatment-related adverse events, anddemonstrates encouraging efficacy signals   GlobeNewswire Inc
May 3, 2021
08:00AM EDT  Beyond Air Appoints Peter Senior as Director of   GlobeNewswire Inc
Apr 28, 2021
10:25AM EDT  Truist Securities Initiates Coverage On Beyond Air with Buy Rating, Announces Price Target of $12   Benzinga
Apr 14, 2021
08:00AM EDT  Beyond Air Announces Participation at Upcoming   GlobeNewswire Inc
Mar 24, 2021
08:00AM EDT  Beyond Air to Present Abstracts at the American   GlobeNewswire Inc
Mar 5, 2021
11:49AM EST  Insider Buys Beyond Air's Shares   Benzinga
Mar 1, 2021
08:00AM EST  Beyond Air Announces Participation at Upcoming Virtual   GlobeNewswire Inc
Feb 16, 2021
08:10AM EST  Beyond Air Receives Grant for Up to $2.17M From the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary Disease   Benzinga
08:00AM EST  Award will help fund the development of high concentration nitric oxide (NO) for Nontuberculous Mycobacteria (NTM) pulmonary disease, which disproportionately affects cystic fibrosis (CF) patients   GlobeNewswire Inc
Feb 9, 2021
04:46PM EST  Beyond Air: Q3 Earnings Insights   Benzinga
04:20PM EST  Beyond Air Q3 EPS $(0.33) Misses $(0.31) Estimate, Sales $148.79K Miss $270.00K Estimate   Benzinga
04:05PM EST  U.S. FDA reviewing premarket approval (PMA) submission for LungFitTM PH to treat persistent pulmonary hypertension of the newborn (PPHN), as Company prepares for commercialization   GlobeNewswire Inc
04:05AM EST  Earnings Scheduled For February 9, 2021   Benzinga
Jan 15, 2021
04:10PM EST  Beyond Air Schedules Third Fiscal Quarter 2021   GlobeNewswire Inc
Dec 7, 2020
08:27AM EST  CORRECTION: Beyond Air Ticker Is 'XAIR'   Benzinga
08:26AM EST  Beyond Air Initiates Patient Screening For LungFit GO Pilot Study For At-Home, Self-Administration Of Inhaled Nitric Oxide In Nontuberculous Mycobacteria Lung Disease   Benzinga
08:00AM EST  Expect to dose first patient in January 2021 and report interim data mid-2021   GlobeNewswire Inc
Nov 19, 2020
08:00AM EST  Beyond Air to Participate in the 32nd Annual Piper   GlobeNewswire Inc
Nov 12, 2020
10:14AM EST  Beyond Air shares were trading higher after the company reported better-than-expected Q2 sales results.   Benzinga
Nov 11, 2020
04:33PM EST  Recap: Beyond Air Q2 Earnings   Benzinga
04:12PM EST  Beyond Air Q2 EPS $(0.30), Inline, Sales $350.00K Beat $120.00K Estimate   Benzinga
04:10PM EST  Submitted a premarket approval (PMA)to the FDA for LungFitPH to treat persistent pulmonary hypertension of the newborn (PPHN)   GlobeNewswire Inc
07:38AM EST  Beyond Air Submits PMA Application To FDA For LungFit PH To Treat Persistent Pulmonary Hypertension Of Newborn   RTTNews
07:34AM EST  Beyond Air Reports Submission Of Premarket Approval Application To FDA For LungFit PH To Treat Persistent Pulmonary Hypertension Of The Newborn   Benzinga
07:30AM EST  Potential to revolutionize nitric oxide therapy by eliminating need for cumbersome cylinders creating improved economics and safety in hospital setting   GlobeNewswire Inc
04:09AM EST  Earnings Scheduled For November 11, 2020   Benzinga
Oct 23, 2020
08:00AM EDT  Beyond Air Schedules Second Fiscal Quarter 2021   GlobeNewswire Inc
Oct 21, 2020
07:07AM EDT  Beyond Air Approved to Initiate Clinical Study At 150 ppm Nitric Oxide With LungFit For The Treatment Of Acute Viral Pneumonia Including COVID-19   Benzinga
07:00AM EDT  Patients with pneumonia caused by any virus, including SARS-CoV-2, will be considered for enrollment   GlobeNewswire Inc
Oct 19, 2020
10:04AM EDT  Beyond Air Presents In Vivo Solid Tumor Data Confirming In Situ Cancer Vaccination With A Single Injection Of Gaseous Nitric Oxide At AACR Conference On Tumor Immunology And Immunotherapy Today   Benzinga
10:01AM EDT  New in vivo data for colon cancer show anti-tumor immunity in 100% of mice   GlobeNewswire Inc
07:15AM EDT  In vitro data support development of nitric oxide as a potential coronavirus therapy that acts within hours   GlobeNewswire Inc
07:02AM EDT  Beyond Air Highlights Presentation Of Pilot Bronchiolitis Data At CHEST Annual Meeting 2020   Benzinga
07:00AM EDT  150ppm nitric oxide was statistically significant compared to both control and 85ppm nitric oxide arms on the primary and key secondary endpoints   GlobeNewswire Inc
Oct 16, 2020
08:09AM EDT  Beyond Air Presents New Preclinical Data For Use Of A Single Injection Of Gaseous Nitric Oxide As A Novel In situ Cancer Vaccination   Benzinga
08:00AM EDT  Beyond Air Presents Positive New Preclinical Data for   GlobeNewswire Inc
Sep 30, 2020
08:00AM EDT  Beyond Air to Present Data on Nitric Oxide in the   GlobeNewswire Inc
Sep 11, 2020
08:00AM EDT  Beyond Air to Present at the Oppenheimer & Co. Fall Healthcare   GlobeNewswire Inc
Sep 9, 2020
08:06AM EDT  Beyond Air To Present Posters On Coronavirus, Bronchiolitis At CHEST 2020 Annual Meeting   Benzinga
08:00AM EDT  Beyond Air to Present Posters on CoronaVirus and   GlobeNewswire Inc
Aug 27, 2020
08:04AM EDT  Beyond Air To Present New Nitric Oxide Data In An E-Poster Presentation At The North America Conference On Lung Cancer 2020   Benzinga
08:01AM EDT  Beyond Air to Present New Nitric Oxide Data in an   GlobeNewswire Inc
Aug 18, 2020
05:06PM EDT  Beyond Air Announces On August 12, Co. Entered Manufacture And Supply Agreement For Medical Products With Medisize Ireland Limited   Benzinga
Aug 10, 2020
04:01PM EDT  Beyond Air Publishes New Data on Nitric Oxide to Treat M.   GlobeNewswire Inc
Aug 6, 2020
07:46AM EDT  Beyond Air Q1 EPS $(0.40) Misses $(0.31) Estimate, Sales $229.16K Beat $210.00K Estimate   Benzinga
07:45AM EDT  U.S. COVID-19 study showing positive safety profile for patients enrolled to date   GlobeNewswire Inc
Jul 23, 2020
08:00AM EDT  Beyond Air to Announce Fiscal First Quarter 2021   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC